Cite
HARVARD Citation
Brennan, Y. et al. (2020). The Australian experience with switching to extended half‐life factor VIII and IX concentrates: On behalf of the Australian Haemophilia Centre Directors' Organisation. Haemophilia. 26 (3), pp. 529-535. [Online].